Lei Mou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lei Mou has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
Zijie Li
8 shared publicationsYong Xia
7 shared publicationsZhiqi Li
7 shared publicationsYongmei Chen
Department of Clinical Laboratory, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, No. 63 Duobao Road, Liwan District, Guangzhou, Guangdong, 510150, PR China
6 shared publicationsRubing Xiong
5 shared publicationsChenfei Liu
4 shared publications
Latest Publications
- 18 August 2026
- Published by Wiley in Analysis & Sensing
- Vol. 6 (5)
Screen‐Printed Electrode‐Based Biosensors for POCT and Wearable Applications: A Review
The growing demand for rapid, decentralized, and continuous health monitoring is driving the development of point‐of‐care testing (POCT) and wearable biosensing technologies. Electrochemical sensors have emerged as a leading platform owing to their high sensitivity, rapid response, and compatibility with miniaturized systems. Among these, screen‐printed electrodes (SPEs) offer distinct advantages, including low cost, scalable fabrication, and facile integration into portable devices. This mini‐review summarizes recent advances in SPE‐based electrochemical biosensors, focusing on fabrication strategies, surface modification approaches, and emerging biomedical applications. The incorporation of functional materials has significantly improved analytical performance, enabling sensitive and selective detection of diverse biomarkers—from small molecules and ions to hormones, proteins, and nucleic acids—in biofluids such as blood, sweat, and interstitial fluid (ISF). These developments have facilitated practical implementations in POCT and wearable systems. Current challenges and future perspectives are also discussed, including scalable manufacturing, long‐term operational stability, and system‐level integration. This review provides a concise overview of recent progress and highlights opportunities for advancing next‐generation portable and wearable biosensing platforms.
- 18 August 2026
- Published by Wiley in Analysis & Sensing
- Vol. 6 (5)
Screen‐Printed Electrode‐Based Biosensors for POCT and Wearable Applications: A Review
The growing demand for rapid, decentralized, and continuous health monitoring is driving the development of point‐of‐care testing (POCT) and wearable biosensing technologies. Electrochemical sensors have emerged as a leading platform owing to their high sensitivity, rapid response, and compatibility with miniaturized systems. Among these, screen‐printed electrodes (SPEs) offer distinct advantages, including low cost, scalable fabrication, and facile integration into portable devices. This mini‐review summarizes recent advances in SPE‐based electrochemical biosensors, focusing on fabrication strategies, surface modification approaches, and emerging biomedical applications. The incorporation of functional materials has significantly improved analytical performance, enabling sensitive and selective detection of diverse biomarkers—from small molecules and ions to hormones, proteins, and nucleic acids—in biofluids such as blood, sweat, and interstitial fluid (ISF). These developments have facilitated practical implementations in POCT and wearable systems. Current challenges and future perspectives are also discussed, including scalable manufacturing, long‐term operational stability, and system‐level integration. This review provides a concise overview of recent progress and highlights opportunities for advancing next‐generation portable and wearable biosensing platforms.
- 23 July 2026
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1421, 346006
Oxygen-adaptive continuous lactate monitoring via dual-regime electrochemical sensing and dynamic calibration strategy
- 23 July 2026
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1421, 346006
Oxygen-adaptive continuous lactate monitoring via dual-regime electrochemical sensing and dynamic calibration strategy
- 1 July 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (7) , 5942-5953
Robust and Sensitive Electrochemical Biosensor Based on Cascade Interface Engineering for piRNA Detection in Breast Cancer Diagnosis
Point-of-care electrochemical sensors require interfaces that simultaneously deliver high sensitivity, mechanical robustness, and long-term stability. These requirements remain difficult to reconcile at nanostructured electrode interfaces. Here, we report a cascade interfacial engineering strategy that integrates plasma-synthesized polydopamine (PDA), MXene nanosheets, and gold nanoparticles (AuNPs) to construct a high-performance electrochemical sensing interface. A rapid, one-minute plasma process forms a conductive PDA interlayer that serves both as a universal adhesive and as a mediator for the in situ electrodeposition of MXene and pH-regulated AuNPs, yielding a mechanically resilient and highly conductive nanocomposite electrode. This architecture markedly enhances electroactive surface area, electron transport, and interfacial stability under repeated mechanical deformation and prolonged storage. When coupled with catalytic hairpin assembly, the resulting platform enables ultrasensitive nucleic acid detection down to the femtomolar regime (within the linear range of 0–100 nM, the limits of detection are 0.14, 0.44, and 0.06 fM, respectively) and maintains high reproducibility across batches (RSD as low as 2.05%). Integration with a portable printed circuit board further enables reliable analysis of clinical serum samples. Beyond a specific biosensing application, this work establishes a generalizable interface-engineering paradigm for stabilizing nanomaterial-modified electrodes, advancing the design of robust, scalable point-of-care electrochemical systems.
- 1 July 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (7) , 5942-5953
Robust and Sensitive Electrochemical Biosensor Based on Cascade Interface Engineering for piRNA Detection in Breast Cancer Diagnosis
Point-of-care electrochemical sensors require interfaces that simultaneously deliver high sensitivity, mechanical robustness, and long-term stability. These requirements remain difficult to reconcile at nanostructured electrode interfaces. Here, we report a cascade interfacial engineering strategy that integrates plasma-synthesized polydopamine (PDA), MXene nanosheets, and gold nanoparticles (AuNPs) to construct a high-performance electrochemical sensing interface. A rapid, one-minute plasma process forms a conductive PDA interlayer that serves both as a universal adhesive and as a mediator for the in situ electrodeposition of MXene and pH-regulated AuNPs, yielding a mechanically resilient and highly conductive nanocomposite electrode. This architecture markedly enhances electroactive surface area, electron transport, and interfacial stability under repeated mechanical deformation and prolonged storage. When coupled with catalytic hairpin assembly, the resulting platform enables ultrasensitive nucleic acid detection down to the femtomolar regime (within the linear range of 0–100 nM, the limits of detection are 0.14, 0.44, and 0.06 fM, respectively) and maintains high reproducibility across batches (RSD as low as 2.05%). Integration with a portable printed circuit board further enables reliable analysis of clinical serum samples. Beyond a specific biosensing application, this work establishes a generalizable interface-engineering paradigm for stabilizing nanomaterial-modified electrodes, advancing the design of robust, scalable point-of-care electrochemical systems.
- 26 May 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (22) , 16387-16401
Dancing on Electrodes: Wearable Continuous Multiplexed Monitoring for Daily Diabetic Nephropathy Management
Diabetic nephropathy has become a serious public health issue, yet current continuous glucose monitoring devices fail to provide comprehensive insights for DN patients. Here, we develop a continuous multiplexed monitoring (CMM) system for the simultaneous monitoring of three key biomarkers: pH, glucose (Glu), and uric acid (UA). We propose the "W-C-W" electrode multiplexing strategy: depositing polyaniline (PANI) nanofiber to construct a pH sensor ("W" mode), then reusing this electrode as the counter electrode for Glu and UA sensors ("C" mode). This strategy enables approximately five pH calibration times for Glu and UA sensors. The sensors exhibit excellent sensing performance (sensitivities of the pH, Glu, and UA sensors are 69.7 mV/pH, 5.71 nA/mM, and 163 nA/mM, respectively) and excellent in vitro and in vivo biocompatibility. We validated the system's pH self-calibration function and long-term monitoring for Glu and UA in SD rats. The results showed the detection error decreased and a high correlation with the commercial clinical-use devices, indicating significant potential for application in daily health management for DN patients.
- 26 May 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (22) , 16387-16401
Dancing on Electrodes: Wearable Continuous Multiplexed Monitoring for Daily Diabetic Nephropathy Management
Diabetic nephropathy has become a serious public health issue, yet current continuous glucose monitoring devices fail to provide comprehensive insights for DN patients. Here, we develop a continuous multiplexed monitoring (CMM) system for the simultaneous monitoring of three key biomarkers: pH, glucose (Glu), and uric acid (UA). We propose the "W-C-W" electrode multiplexing strategy: depositing polyaniline (PANI) nanofiber to construct a pH sensor ("W" mode), then reusing this electrode as the counter electrode for Glu and UA sensors ("C" mode). This strategy enables approximately five pH calibration times for Glu and UA sensors. The sensors exhibit excellent sensing performance (sensitivities of the pH, Glu, and UA sensors are 69.7 mV/pH, 5.71 nA/mM, and 163 nA/mM, respectively) and excellent in vitro and in vivo biocompatibility. We validated the system's pH self-calibration function and long-term monitoring for Glu and UA in SD rats. The results showed the detection error decreased and a high correlation with the commercial clinical-use devices, indicating significant potential for application in daily health management for DN patients.
- 10 September 2025
- Published by Elsevier in Journal of Biotechnology
- Vol. 408, 132-141
A universal single-plasmid, single-promoter system for efficient protein display and RNA encapsulation in MS2 virus-like particles
- 10 September 2025
- Published by Elsevier in Journal of Biotechnology
- Vol. 408, 132-141
A universal single-plasmid, single-promoter system for efficient protein display and RNA encapsulation in MS2 virus-like particles
- Open Access
- 7 May 2025
- Published by Springer Nature in Research Square
A Novel Machine Learning-enhanced Microfluidic CircRNAs Detection Platform for Breast Cancer Precision Diagnosis
The discovery and favourable detection of breast cancer biomarkers are significant for cancer diagnosis. Here, we show that hsa_circ_044235 and hsa_circ_000250 are effective biomarkers for breast cancer diagnosis. Moreover, we present an integrated electrochemical microfluidic circRNAs detection platform (ECMCDP) that combined gold platinum nanoparticles (AuPts)-modified screen-printed electrodes (SPEs), catalytic hairpin assembly (CHA), electrochemical microfluidic chip and a customed low-power electronic system for simultaneous detection of two breast cancer-associated circRNAs. The limit of detection (LOD) were 0.12 fM and 0.1 fM, and the diagnostic accuracy were 92.50% and 88.75% in clinical blood samples, respectively. The platform was validated using paired pre-/post-operative blood and tissue samples. Combined with five machine learning-based diagnostic models, the ensemble diagnosis model achieved a high accuracy of 93.75%. This work aims to identify novel breast cancer biomarkers and establish an innovative circRNAs detection platform to improve breast cancer diagnosis and support clinical prognosis assessment.
- 7 May 2025
- Published by Springer Nature in Research Square
Open AccessA Novel Machine Learning-enhanced Microfluidic CircRNAs Detection Platform for Breast Cancer Precision Diagnosis
The discovery and favourable detection of breast cancer biomarkers are significant for cancer diagnosis. Here, we show that hsa_circ_044235 and hsa_circ_000250 are effective biomarkers for breast cancer diagnosis. Moreover, we present an integrated electrochemical microfluidic circRNAs detection platform (ECMCDP) that combined gold platinum nanoparticles (AuPts)-modified screen-printed electrodes (SPEs), catalytic hairpin assembly (CHA), electrochemical microfluidic chip and a customed low-power electronic system for simultaneous detection of two breast cancer-associated circRNAs. The limit of detection (LOD) were 0.12 fM and 0.1 fM, and the diagnostic accuracy were 92.50% and 88.75% in clinical blood samples, respectively. The platform was validated using paired pre-/post-operative blood and tissue samples. Combined with five machine learning-based diagnostic models, the ensemble diagnosis model achieved a high accuracy of 93.75%. This work aims to identify novel breast cancer biomarkers and establish an innovative circRNAs detection platform to improve breast cancer diagnosis and support clinical prognosis assessment.
- Top Cited Papers
- 22 April 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (17) , 16980-16994
A Gold Nanoparticles and MXene Nanocomposite Based Electrochemical Sensor for Point-of-Care Monitoring of Serum Biomarkers
The development of portable, cost-effective, and highly sensitive biosensors for real-time biomarker detection is crucial for advancing point-of-care testing (POCT) and wearable health monitoring. Here, we present an integrated portable electrochemical sensor (ip-ECS) that combines gold nanoparticles (AuNPs) and MXene-modified screen-printed electrodes (SPEs) with a custom-designed, low-power electronic system for point-of-care monitoring of serum biomarkers. The AuNPs and MXene nanocomposite significantly enhances the electrochemical performance of the SPE by providing a high density of active sites, improved conductivity, and catalytic activity. The detection of two model molecules (DA and UA) validated the feasibility of ip-ECS, achieving detection limits as low as 1.12 and 1.11 μM for UA and DA, respectively. Furthermore, the ip-ECS was successfully applied to detect Cys C in human serum, showing a linear response in the range of 50-5000 ng/mL and a strong correlation (ρ = 0.9556) with conventional latex immunoturbidimetry (LIA). Clinical validation using serum samples from pregnant women revealed elevated Cys C levels in gestational diabetes mellitus (GDM) patients, highlighting the sensor's potential for early GDM risk prediction. The ip-ECS represents a significant step forward in the development of next-generation biosensors for POCT, wearable diagnostics, and personalized medicine.
- 22 April 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (17) , 16980-16994
Top Cited PapersA Gold Nanoparticles and MXene Nanocomposite Based Electrochemical Sensor for Point-of-Care Monitoring of Serum Biomarkers
The development of portable, cost-effective, and highly sensitive biosensors for real-time biomarker detection is crucial for advancing point-of-care testing (POCT) and wearable health monitoring. Here, we present an integrated portable electrochemical sensor (ip-ECS) that combines gold nanoparticles (AuNPs) and MXene-modified screen-printed electrodes (SPEs) with a custom-designed, low-power electronic system for point-of-care monitoring of serum biomarkers. The AuNPs and MXene nanocomposite significantly enhances the electrochemical performance of the SPE by providing a high density of active sites, improved conductivity, and catalytic activity. The detection of two model molecules (DA and UA) validated the feasibility of ip-ECS, achieving detection limits as low as 1.12 and 1.11 μM for UA and DA, respectively. Furthermore, the ip-ECS was successfully applied to detect Cys C in human serum, showing a linear response in the range of 50-5000 ng/mL and a strong correlation (ρ = 0.9556) with conventional latex immunoturbidimetry (LIA). Clinical validation using serum samples from pregnant women revealed elevated Cys C levels in gestational diabetes mellitus (GDM) patients, highlighting the sensor's potential for early GDM risk prediction. The ip-ECS represents a significant step forward in the development of next-generation biosensors for POCT, wearable diagnostics, and personalized medicine.
- 13 February 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (12) , 3906-3917
A liquid metal-based sticky conductor for wearable and real-time electromyogram monitoring with machine learning classification
This study presents an LM–PDMS sticky conductor with high conductivity, flexibility, and strong adhesion, achieving 83.33% accuracy in EMG-based muscle movement classification, demonstrating its potential for real-time monitoring and rehabilitation.
- 13 February 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (12) , 3906-3917
A liquid metal-based sticky conductor for wearable and real-time electromyogram monitoring with machine learning classification
This study presents an LM–PDMS sticky conductor with high conductivity, flexibility, and strong adhesion, achieving 83.33% accuracy in EMG-based muscle movement classification, demonstrating its potential for real-time monitoring and rehabilitation.
- 13 January 2025
- Published by Elsevier in Bioelectrochemistry
- Vol. 163, 108907
Enhanced detection of Cystatin C for predicting adverse outcomes in gestational diabetes mellitus using a point-of-care immunosensor
- 13 January 2025
- Published by Elsevier in Bioelectrochemistry
- Vol. 163, 108907
Enhanced detection of Cystatin C for predicting adverse outcomes in gestational diabetes mellitus using a point-of-care immunosensor